Collaborations & Alliances
Related Searches:
Filter by:
March 27, 2008
Quintiles Transnational has signed an agreement with Medca Japan to provide central laboratory services in Japan. Quintiles will have its own staff at the College of American Pathologoists-certified Medca laboratory in Saitama, a city in the Greater…
Read More »
March 26, 2008
ArQule, Inc. has received a milestone payment from Wyeth in connection with the filing of an Investigational New Drug (IND) application by Wyeth to the FDA related to a compound under development for Alzheimer’s disease.
In connection with i…
Read More »
March 25, 2008
Millennium Biotechnologies, Inc. has entered into a five-year exclusive distribution agreement for Resurgex, its nutritional formula for immuno-comprised patients, with Ferring, Inc. of Canada, a division of Ferring S.A.
Under the ag…
Read More »
March 18, 2008
Sartorius Stedim Biotech and ProMetic Life Sciences Inc. enter the second successful technology transfer deal resulting from the companies' 2006 collaboration. Through the collaboration, Sartorius Stedim Biotech is the supplier and technology provide…
Read More »
March 14, 2008
Genentech, Inc. has exercised its option to further develop and commercialize Exelixis Inc.'s compound XL518, a selective and potent inhibitor of MEK that is currently in a Phase I trial. Under the terms of the agreement, Exelixis will continue that…
Read More »
March 14, 2008
Eli Lilly and Co. and Transition Therapeutics, Inc. have entered into a licensing and collaboration agreement granting Lilly exclusive worldwide rights to develop and commercialize Transition's gastrin-based therapies, including the lead compound TT-…
Read More »
March 14, 2008
AstraZeneca and Silence Therapeutics have entered into a collaboration focused on the development of new approaches for the delivery of siRNA molecules. Silence has expertise in the delivery of siRNA molecules, in particular with the functional syste…
Read More »
March 10, 2008
Abbott's molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche and OSI Pharmaceuticals, Inc. to develop a gene test to assess the clinical benefit of Tarceva, an oral tablet indicated for the treatmen…
Read More »
March 4, 2008
Penn Pharmaceutical Services and Specials Clinical Manufacturing have entered into a strategic alliance to provide outsourced services in sterile manufacturing, packing and distribution of investigational medicinal products (IMPs).
…
Read More »
February 29, 2008
Wyeth Pharmaceuticals has ended its collaboration agreements with Solvay Pharmaceuticals for the development and commercialization of bifeprunox, an investigational atypical antipsychotic drug, as well as other compounds in earlier stages of developm…
Read More »
February 19, 2008
Memory Pharmaceuticals Corp. plans to conduct a clinical study of MEM 3454, the company's lead nicotinic alpha-7 partial agonist, in patients with schizophrenia based on two biomarkers, P50 sensory gating and mismatch negativity. Development partner,…
Read More »
February 5, 2008
Amgen and Takeda Pharmaceutical Co. Ltd. entered an agreement under which Takeda will develop and commercialize as many as 13 molecules from Amgen’s pipeline for the Japanese market. The collaboration includes early to mid-clinical-stage candid…
Read More »
January 22, 2008
Bristol-Myers Squibb has exercised its option to develop and commercialize Exelixis' compound XL139. Exelixis will receive a $20 million milestone payment and has exercised its option to co-develop and co-commercialize the drug in the U.S. BMS will l…
Read More »
January 18, 2008
Azopharma Product Development Group, Inc. and Accu-Break Pharmaceuticals, Inc. (ABP) have signed a strategic alliance agreement in which Azopharma will develop products based on ABP’s Accu-Break tablet technologies. The agreement spans five yea…
Read More »
January 18, 2008
Helix BioPharma Corp. has signed an agreement with KBI Biopharma, Inc. to develop a process for preparing L-DOS47 in a lyophilized (freeze-dried powder) vial format for clinical testing.
"This new arrangement advances the C…
Read More »
